Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens
R
R
Weinberger
M
M
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D000420:Albuterol / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D016535:Bronchial Hyperreactivity / Q000209:etiology; D001986:Bronchial Spasm / Q000209:etiology; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D004361:Drug Tolerance; D006801:Humans; D013237:Stereoisomerism
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000420:Albuterol